← Back to Clinical Trials
Recruiting NCT06083220

NCT06083220 School Readiness in Preschool-Aged Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06083220
Status Recruiting
Phase
Sponsor Texas Scottish Rite Hospital for Children
Condition Unilateral Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2023-12-12
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 36 Months
Max Age 71 Months
Study Type INTERVENTIONAL
Interventions
Smart Start - School Readiness Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2023-12-12 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this feasibility and proof of concept study is to learn about the feasibility, acceptability, and impact of a school readiness program for preschool-aged children with unilateral cerebral palsy. The main question\[s\] it aims to answer are: 1. Is it feasible to implement an intensive school readiness program for preschool-aged children with UCP? 2. Is the program acceptable to the children and their caregivers? 3. What is the impact of the program on school readiness? Participants will complete two pre-intervention assessments, participate in an intensive, goal directed, school readiness program, and complete 1 post-intervention assessment.

Eligibility Criteria

Inclusion Criteria: * ages 3 years to 5 years 11 months * unilateral cerebral palsy * ability to visually attend to objects * demonstrates an interest in objects * attempt to reach for or grasp an item with the impaired upper extremity * English-speaking participants Exclusion Criteria: * uncontrolled epilepsy * significant visual impairment * severe behavioral problems * inability to complete the assessment protocol

Contact & Investigator

Central Contact

Angela Shierk, PhD

✉ angela.shierk@tsrh.org

📞 (469) 412-7172

Principal Investigator

Angela Shierk, PhD

PRINCIPAL INVESTIGATOR

Scottish Rite for Children

Frequently Asked Questions

Who can join the NCT06083220 clinical trial?

This trial is open to participants of all sexes, aged 36 Months or older, up to 71 Months, studying Unilateral Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06083220 currently recruiting?

Yes, NCT06083220 is actively recruiting participants. Contact the research team at angela.shierk@tsrh.org for enrollment information.

Where is the NCT06083220 trial being conducted?

This trial is being conducted at Frisco, United States.

Who is sponsoring the NCT06083220 clinical trial?

NCT06083220 is sponsored by Texas Scottish Rite Hospital for Children. The principal investigator is Angela Shierk, PhD at Scottish Rite for Children. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology